The Heavier Hitters
First want to thank everyone for their comments on the new site and appreciate your patience as we fixed some of the glitches. There are still some changes on the way, but the major redesign phase is now complete.
Abbott reported this morning and as expected Libre sales continue to expand nothing new here. The key takeaways are this:
1. No update on the launch of the Libre 3 which was also expected. As a side note here it’s time for everyone to realize that FDA is majorly backed up when it comes to new device approvals. This is . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.